Skip to main content

Table 1 Patient characteristics

From: Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis—a cohort study of 123 patients from a non-endemic country

 

SRCC group (n = 62)

Non-SRCC group (n = 61)

p

Age (years)

54.88 ± 12.59

62.47 ± 15.48

0.004

Sex

Female

38 (61.3%)

20 (32.8%)

0.002

Male

24 (38.7%)

41 (67.2%)

 

Family history of cancer

Gastric cancer

0

1

0.65

Digestive cancer

1

0

0.45

Smoking

18 (29%)

20 (32.8%)

NS

Gastric ulcer

3 (4.8%)

5 (8.2%)

NS

HP infection

12 (19.4%)

12 (19.7%)

NS

Time to first diagnosis (day)

202 ± 232

182 ± 210

0.62

Body mass index (kg/m2)

21.73 ± 4.48

20.99 ± 4.45

0.59

Diagnosis circumstances

Hematemesis

0

12 (19.7%)

0.001

Melena

0

6 (9.8%)

0.03

Anemia

1

9 (14.8%)

0.02

Weight loss

33 (53.2%)

31 (50.8%)

0.79

Dysphagia

26 (41.9%)

29 (47.5%)

0.73

Clinical signs

Epigastric mass

7 (11.3)

4 (6.6)

0.655

Hepatomegaly

1

2

0.836

Ascites

0

0

 

Troisier’s node

0

1